Advances in Hematological Malignancies
Recent years have witnessed remarkable advancements in the field of hematological malignancies. Novel approaches such as targeted agents, immunotherapies, and gene editing are transforming the survival rates for patients with blood cancers. Research studies continue to explore these innovative techn